In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate

Synapse. 2000 Jul;37(1):64-70. doi: 10.1002/(SICI)1098-2396(200007)37:1<64::AID-SYN7>3.0.CO;2-F.

Abstract

The in vitro autoradiographic binding characteristics as well as in vivo imaging characteristics of a dopamine D2 receptor agonist, (R, S)-2-(N-propyl-N-1'-(11)C-propyl)amino-5-hydroxytetralin ((11)C-5-OH-DPAT), were studied. In (3)H-spiperone assays using rat striata, 5-OH-DPAT exhibited an affinity of IC(50) = 2.5 nM. In vitro autoradiographs in rat brain slices with (11)C-5-OH-DPAT revealed selective binding to the dopaminergic regions in the striata which was displaceable by sulpiride. Varying concentrations of dopamine displaced this selective binding of (11)C-5-OH-DPAT to the striata in rat brain slices. This selective binding to the striata was also removed in the presence of the GTP analog, 5'-guanylylimidodiphosphate, indicative of the binding of (11)C-5-OH-DPAT to the high-affinity state of the D2 receptor. Ex vivo autoradiographic study in rats exhibited selective binding of (11)C-5-OH-DPAT to the striata. A PET study in a rhesus monkey showed selective localization of (11)C-5-OH-DPAT in the striata and the ratio between striata and cerebellum approached approximately 2 at 40 min postinjection.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / analogs & derivatives*
  • 8-Hydroxy-2-(di-n-propylamino)tetralin / chemistry
  • 8-Hydroxy-2-(di-n-propylamino)tetralin / metabolism
  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Autoradiography
  • Brain / diagnostic imaging
  • Brain Chemistry*
  • Carbon Radioisotopes
  • Dopamine Agonists / chemistry
  • Dopamine Agonists / metabolism
  • Dopamine Agonists / pharmacology*
  • In Vitro Techniques
  • Macaca mulatta
  • Male
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / agonists*
  • Receptors, Dopamine D2 / metabolism*
  • Tomography, Emission-Computed

Substances

  • Carbon Radioisotopes
  • Dopamine Agonists
  • Receptors, Dopamine D2
  • 5-hydroxy-2-N,N-dipropylaminotetralin
  • 8-Hydroxy-2-(di-n-propylamino)tetralin